Mechanisms of skin aging induced by EGFR inhibitors

Peter Arne Gerber1, Bettina Alexandra Buhren2, Holger Schrumpf2

  • 1Department of Dermatology, Medical Faculty, University of Düsseldorf, Moorenstrasse 5, D-40225, Duesseldorf, Germany. peterarne.gerber@med.uni-duesseldorf.de.

Abstract

Insights

Epidermal Growth Factor Receptor (EGFR) inhibition accelerates skin aging by altering keratinocyte function. This study investigated the molecular mechanisms behind these aging-like skin changes observed in patients.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Oncology

Background:

  • The precise mechanisms driving skin aging remain incompletely understood.
  • Anecdotal evidence suggests that inhibiting the Epidermal Growth Factor Receptor (EGFR) may accelerate skin aging.
  • This study investigates the link between EGFR inhibition and aging-like skin changes.

Purpose of the Study:

  • To clinically characterize skin changes associated with Epidermal Growth Factor Receptor Inhibitor (EGFRIs) use.
  • To explore the cellular and molecular mechanisms underlying these treatment-induced skin alterations.
  • To compare EGFR expression in young versus aged skin.

Main Methods:

  • Analysis of patients undergoing prolonged EGFRIs treatment for aging-like skin changes.
  • In vitro study of primary human keratinocytes treated with erlotinib.
  • Assessment of extracellular matrix regulation, senescence markers, and cell cycle status.
  • Comparison of baseline EGFR expression in young (<25 years) and aged (>65 years) skin.

Main Results:

  • 12 patients exhibited progressive aging signs: xerosis cutis, atrophy, rhytide formation, and actinic purpura.
  • Erlotinib treatment in keratinocytes led to decreased hyaluronan synthases (HAS2, HAS3).
  • Senescence-associated genes (p21, p53, IL-6, maspin) were upregulated, with G1 cell cycle arrest and increased SA β-Gal activity.
  • Aged skin showed significantly lower baseline EGFR density compared to young skin.

Conclusions:

  • EGFR inhibition induces molecular changes in keratinocytes.
  • These alterations likely contribute to the observed skin aging in patients receiving EGFRIs.
  • Findings provide insight into the pathogenesis of treatment-related skin aging.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.2K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
967
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
797